Supplier SurModics Builds Up Whole-Products Strategy With Two Acquisitions
This article was originally published in The Gray Sheet
Executive Summary
After recent buys of Creagh Medical and now NorMedix, device coatings and IVD specialty firm SurModics says it has built its business as a whole-product solutions provider to device companies.
You may also be interested in...
New EU Filings
Omaveloxolone, Reata Pharmaceuticals’s orphan drug for treating patients with Friedreich’s ataxia, is among the latest drugs that have been filed for review by the European Medicines Agency for potential EU marketing approval.
UK Guidance Tackles Social Media ‘Compliance Headache’ For Pharma
Announcing product milestones and liking LinkedIn posts are just some of the topics addressed in a long-awaited guidance that deals with the challenges prescription drug makers face in the UK when using social media.
FDA Urged To Collaborate With USPTO On Orange Book Listings, Eliminate Patent Use Codes
Stakeholders suggest a variety of USPTO and FDA actions that could help ensure patents do not improperly delay generic and biosimilar competition.